THE APEX TIMES
The automaker says it has started shipping early batches of LFP battery cells from a Michigan facility, highlighting its push to broaden battery chemistry options alongside supplier partner CATL.
Ford has started shipping what it describes as its first lithium-iron-phosphate, or LFP, battery cells from its Michigan plant, according to a report carried by Yahoo Finance and published by just-auto.
The announcement indicates a practical step in Ford’s battery strategy as automakers seek supply flexibility and cost control for electric-vehicle packs. LFP is a widely used battery chemistry that trades energy density for improved durability and, in many cases, lower material costs compared with nickel- and cobalt-heavy alternatives.
Ford’s path to LFP in the U.S. has been closely tied to its work with China’s CATL on the technology. CATL has supplied and licensed LFP-related know-how across the industry, and the latest shipping milestone described in the report suggests Ford is translating that partnership into physical production.
The report does not lay out pack or vehicle details in the way investors typically want, such as which specific Ford models will receive these cells first, what the shipment volumes are, or whether the cells are being used in customer vehicles or in-house validation. Ford also does not appear to have disclosed timeline specifics for full-scale capacity or ramp rates in the cited post.
For Ford, moving from development and qualification to shipments matters because battery procurement and production timing can be as important as technology choice. Cells that are ready to ship can help reduce delays caused by supply bottlenecks, and using LFP can offer a different set of trade-offs for cost, thermal performance, and manufacturing planning.
In the broader auto sector, LFP supply has become an area of intense focus because it can change the economics of electric-vehicle programs. While automakers have used different chemistries over time, the industry shift toward LFP in many regions reflects both customer demand for competitive pricing and pressure on battery costs.
Still, several questions remain unanswered based on the limited disclosure in the report. It is unclear how much of Ford’s Michigan output will be dedicated to LFP cells, whether additional chemistries are also in production there, and what proportion of the shipped cells will ultimately flow into consumer vehicles versus internal testing and inventory building.
A market-focused note argues the company’s cash-return profile could matter as Wall Street debates whether 2027 can resemble 2022. The company, however, did not provide new disclosure in the cited post.
A market report said the U.S. Securities and Exchange Commission has opened an investigation involving Nvidia as the chipmaker absorbs fallout from a sharp selloff. Investors now have to parse what the agency is looking at and how much the matter could weigh on disclosures and governance.
A reported Phase 3 win for Moderna’s personalized melanoma therapy, used alongside Merck’s Keytruda, is prompting fresh optimism that the mRNA platform can expand beyond infectious disease. Still, key details such as magnitude of benefit and full trial disclosure remain to be validated.
Marques Brownlee said he has placed an order for Tesla’s Cybercab following a 2024 challenge, and Tesla CEO Elon Musk replied “fair enough,” saying he would accept delivery.
A new market read on Booz Allen Hamilton Holding points to a sizable gap between the company’s valuation and the cash flow the business can generate, sharpening questions for investors about how durable profits and cash generation are in the defense IT services market.
The company is pursuing Australian National Immunisation Program listings for its mRNA influenza vaccines after securing a March 2027 agenda spot with the PBAC, a key committee that advises public reimbursement.
A newly announced partnership between Microsoft and Danaher aims to pair AI-assisted capabilities with cloud-based scientific instruments and lab software, including early tools that are already moving toward commercial use.
A new market round-up from Yahoo Finance highlights how lingering discussion among Fed officials about whether interest rates need to rise again can reshape expectations for large, consumer-facing companies like PepsiCo.
The initiative, launched within Aetna, is designed to link a large share of expectant members and their newborns to coordinated maternal and infant care. CVS Health has not, in the reporting, disclosed staffing, clinical protocols, or outcome targets tied to the program.
A fresh round of holiday changes at Target centers on shopping hours and promotions, a shift the company is indicating as part of how it intends to drive demand into the end of the year.
Comments
Community guidelines. Comments may be removed for violations.
Loading comments...